Benzinga's Top #PreMarket Losers
December 14, 2015 at 08:22 AM EST
Atara Biotherapeutics Inc (NASDAQ: ATRA) shares dipped 37.38 percent to $20.79 after the company reported results from its Phase 2 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.